Articles tagged "Kidney"

2022 American Transplant Congress
The Impact of New-Onset Diabetes After Transplantation on Survival and Major Cardiovascular Events in Korean Kidney Transplantation Recipients
E. Kang¹, J. Lee², D. Kang³, Y. Jang⁴, S. Park⁵, Y. Kim⁴, D. Kim⁴, K. Joo⁴, Y. Kim⁴, M. Park⁶, Y. Lim⁷, H. Lee⁴
¹Ewha Womans University Seoul Hospital, Seoul, Korea, Republic of, ²Dongguk University Ilsan Hospital, Goyang, Korea, Republic of, ³Chung-Ang University, Seoul, Korea, Republic of, ⁴Seoul National University Hospital, Seoul, Korea, Republic of, ⁵Seoul National University College of Medicine, Seoul, Korea, Republic of, ⁶Informations and Statistics, Chungnam National University, Daejeon, Korea, Republic of, ⁷Applied Statistics, Chung-Ang University, Seoul, Korea, Republic of
*Purpose: New-onset diabetes after transplantation (NODAT) is a frequent complication in kidney transplant (KT) recipients with unfavorable outcomes, although a nationwide study on epidemiology and…
2022 American Transplant Congress
Rapid Formalin-Fixed Deceased Donor Kidney Biopsy Protocol – A Proof Of Concept
M. R. Marvin¹, G. Chen², A. Kotru¹, C. Koo¹, P. Sanghi³, M. Moritz⁴, J. Clarke⁴, R. Hasz⁴
¹Transplant, Geisinger Medical Center, Danville, PA, ²Pathology, Geisinger Medical Center, Danville, PA, ³Transplant Nephrology, Geisinger Medical Center, Danville, PA, ⁴Gift of Life Donor Program, Philadelphia, PA
*Purpose: Reducing kidney discard is a major priority for the transplant community. While frozen section biopsies are the current standard, they are fraught with technical…
2022 American Transplant Congress
Reduction of Discharge Opioid Prescriptions After Kidney Transplantation: A Quality Improvement Project
A. W. Rogers, E. Rizk, J. T. Swan, S. G. Yi, M. Hobeika, R. R. McMillan, J. C. Krisl, H. Podder, A. O. Gaber, R. J. Knight
Houston Methodist Hospital, Houston, TX
*Purpose: Opioid use after kidney transplant has been linked to poorer outcomes, and unused prescriptions can lead to potential misuse. Historical prescribing practice at our…
2022 American Transplant Congress
Increased Mortality After Kidney Transplantation in Mildly Frail Recipients: Need for Pretransplant Intervention
J. Pascual Santos¹, C. Arias-Cabrales¹, D. Redondo-Pachón¹, C. Burballa¹, A. Buxeda¹, A. Bach¹, A. Faura¹, E. Marco², L. Rodríguez-Mañas³, M. Crespo¹, M. J. Pérez-Sáez¹
¹Nephrology, Hospital del Mar, Barcelona, Spain, ²Rehabilitation, Hospital del Mar, Barcelona, Spain, ³Geriatrics, Hospital del Getafe, Getafe, Spain
*Purpose: Frailty is associated with a higher rate of complications and mortality after kidney transplantation (KT). Physical Frailty Phenotype (PFP) is the most used frailty…
2022 American Transplant Congress
The Pre-Transplant Non-HLA Antibody Burden Predicts the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation
A. Senev¹, B. Ray², J. Hariharan², C. Heylen², M. Emonds¹, M. Naesens¹
¹Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, ²Immucor Inc.,, Norcross, GA
*Purpose: Many kidney allografts fail due to the occurrence of antibody-mediated rejection (ABMR), related to donor-specific anti-HLA antibodies (HLA-DSA). However, the histology of ABMR can…
2022 American Transplant Congress
Metastatic BK Virus-Associated Urothelial Carcinoma Originating in Renal Allograft
J. Torrealba¹, H. Jones¹, A. Bhakta², L. Jia¹, D. Wojciechowski²
¹Pathology, UT Southwestern, Dallas, TX, ²Internal Medicine, UT Southwestern, Dallas, TX
*Purpose: Cases of urinary tract carcinoma associated with BK virus have been reported in kidney transplant recipients; therefore, we postulate that BK virus may play…
2022 American Transplant Congress
Feasibility and Short-Term Outcomes of Kidney Transplantation Following Donation After Circulatory Death Using Thoracic Normothermic Regional Perfusion in the United States
L. Hickman, D. Shaffer, J. Hoffman, W. G. McMaster, A. S. Shah, R. Forbes
Surgery, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Organ donation after circulatory death (DCD) is an important component of kidney transplants in the US. Cardiac transplantation from DCD donors has previously been…
2022 American Transplant Congress
Impact of Cyp 3a5 Genotype on Lcp Tacrolimus Dosing and Monitoring in Kidney Transplantation
D. J. Taber, T. Carcella, N. Patel, F. Bartlett, A. Posadas, V. Rao, M. Casey, V. Rohan, D. Dubay, D. Taber
Med Univ of South Carolina, Charleston, SC
*Purpose: LCP Tacrolimus has a recommended de novo starting dose of 0.14 mg/kg/day in kidney transplantation (KTR). There is limited data on the influence of…
2022 American Transplant Congress
Racial Differences in the Predictability of Donor-Derived Cell-Free DNA Among Renal Transplant Recipients
M. D. Williams¹, N. Nimmagadda¹, S. Patel², O. Olaitan¹
¹Rush University Medical Center, Chicago, IL, ²CareDx, Brisbane, CA
*Purpose: Donor-Derived Cell-Free DNA (dd-cfDNA) is used to monitor for allograft rejection following renal transplantation. Baseline dd-cfDNA is higher in African American (AA) patients compared…
2022 American Transplant Congress
Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients
M. Borsh¹, M. Leick¹, A. Donovan², C. McAdam-Marx², M. Keck¹
¹Pharmacy, Nebraska Medicine, Omaha, NE, ²College of Pharmacy, University of Nebraska Medical Center, Omaha, NE
*Purpose: To evaluate if modification of pharmacy discharge education for kidney transplant recipients contributed to a decreased length of hospital stay (LOS) post-transplant.*Methods: This was…